Global and Japan Anti-Viral Drugs Market Insights, Forecast to 2026

Global and Japan Anti-Viral Drugs Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Anti-Viral Drugs Product Introduction
1.2 Market Segments
1.3 Key Anti-Viral Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anti-Viral Drugs Market Size Growth Rate by Type
1.4.2 Nucleotide Polymerase Inhibitor
1.4.3 Reverse Transcriptase Inhibitor
1.4.4 Protease Inhibitor
1.5 Market by Application
1.5.1 Global Anti-Viral Drugs Market Size Growth Rate by Application
1.5.2 HIV
1.5.3 Hepatitis
1.5.4 HSV
1.5.5 Influenza
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anti-Viral Drugs Market Size, Estimates and Forecasts
2.1.1 Global Anti-Viral Drugs Revenue 2015-2026
2.1.2 Global Anti-Viral Drugs Sales 2015-2026
2.2 Global Anti-Viral Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Anti-Viral Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global Anti-Viral Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Anti-Viral Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Anti-Viral Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Anti-Viral Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global Anti-Viral Drugs Revenue Forecast by Region (2021-2026)
3 Global Anti-Viral Drugs Competitor Landscape by Players
3.1 Global Top Anti-Viral Drugs Sales by Manufacturers
3.1.1 Global Anti-Viral Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Anti-Viral Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global Anti-Viral Drugs Manufacturers by Revenue
3.2.1 Global Anti-Viral Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Anti-Viral Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti-Viral Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anti-Viral Drugs Revenue in 2019
3.2.5 Global Anti-Viral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Anti-Viral Drugs Price by Manufacturers
3.4 Global Anti-Viral Drugs Manufacturing Base Distribution, Product Types
3.4.1 Anti-Viral Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-Viral Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Anti-Viral Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Anti-Viral Drugs Market Size by Type (2015-2020)
4.1.1 Global Anti-Viral Drugs Sales by Type (2015-2020)
4.1.2 Global Anti-Viral Drugs Revenue by Type (2015-2020)
4.1.3 Anti-Viral Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anti-Viral Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Anti-Viral Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Anti-Viral Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Anti-Viral Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anti-Viral Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Anti-Viral Drugs Market Size by Application (2015-2020)
5.1.1 Global Anti-Viral Drugs Sales by Application (2015-2020)
5.1.2 Global Anti-Viral Drugs Revenue by Application (2015-2020)
5.1.3 Anti-Viral Drugs Price by Application (2015-2020)
5.2 Anti-Viral Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Anti-Viral Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Anti-Viral Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti-Viral Drugs Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Anti-Viral Drugs Market Size YoY Growth 2015-2026
6.1.1 Japan Anti-Viral Drugs Sales YoY Growth 2015-2026
6.1.2 Japan Anti-Viral Drugs Revenue YoY Growth 2015-2026
6.1.3 Japan Anti-Viral Drugs Market Share in Global Market 2015-2026
6.2 Japan Anti-Viral Drugs Market Size by Players (International and Local Players)
6.2.1 Japan Top Anti-Viral Drugs Players by Sales (2015-2020)
6.2.2 Japan Top Anti-Viral Drugs Players by Revenue (2015-2020)
6.3 Japan Anti-Viral Drugs Historic Market Review by Type (2015-2020)
6.3.1 Japan Anti-Viral Drugs Sales Market Share by Type (2015-2020)
6.3.2 Japan Anti-Viral Drugs Revenue Market Share by Type (2015-2020)
6.3.3 Japan Anti-Viral Drugs Price by Type (2015-2020)
6.4 Japan Anti-Viral Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Anti-Viral Drugs Sales Forecast by Type (2021-2026)
6.4.2 Japan Anti-Viral Drugs Revenue Forecast by Type (2021-2026)
6.4.3 Japan Anti-Viral Drugs Price Forecast by Type (2021-2026)
6.5 Japan Anti-Viral Drugs Historic Market Review by Application (2015-2020)
6.5.1 Japan Anti-Viral Drugs Sales Market Share by Application (2015-2020)
6.5.2 Japan Anti-Viral Drugs Revenue Market Share by Application (2015-2020)
6.5.3 Japan Anti-Viral Drugs Price by Application (2015-2020)
6.6 Japan Anti-Viral Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Anti-Viral Drugs Sales Forecast by Application (2021-2026)
6.6.2 Japan Anti-Viral Drugs Revenue Forecast by Application (2021-2026)
6.6.3 Japan Anti-Viral Drugs Price Forecast by Application (2021-2026)
7 North America
7.1 North America Anti-Viral Drugs Market Size YoY Growth 2015-2026
7.2 North America Anti-Viral Drugs Market Facts & Figures by Country
7.2.1 North America Anti-Viral Drugs Sales by Country (2015-2020)
7.2.2 North America Anti-Viral Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Anti-Viral Drugs Market Size YoY Growth 2015-2026
8.2 Europe Anti-Viral Drugs Market Facts & Figures by Country
8.2.1 Europe Anti-Viral Drugs Sales by Country
8.2.2 Europe Anti-Viral Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Anti-Viral Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific Anti-Viral Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific Anti-Viral Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific Anti-Viral Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Anti-Viral Drugs Market Size YoY Growth 2015-2026
10.2 Latin America Anti-Viral Drugs Market Facts & Figures by Country
10.2.1 Latin America Anti-Viral Drugs Sales by Country
10.2.2 Latin America Anti-Viral Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Anti-Viral Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Anti-Viral Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Anti-Viral Drugs Sales by Country
11.2.2 Middle East and Africa Anti-Viral Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 F. Hoffmann-La Roche
12.1.1 F. Hoffmann-La Roche Corporation Information
12.1.2 F. Hoffmann-La Roche Description and Business Overview
12.1.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
12.1.4 F. Hoffmann-La Roche Anti-Viral Drugs Products Offered
12.1.5 F. Hoffmann-La Roche Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Corporation Information
12.2.2 GlaxoSmithKline Description and Business Overview
12.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GlaxoSmithKline Anti-Viral Drugs Products Offered
12.2.5 GlaxoSmithKline Recent Development
12.3 Bristol-Myers-Squibb
12.3.1 Bristol-Myers-Squibb Corporation Information
12.3.2 Bristol-Myers-Squibb Description and Business Overview
12.3.3 Bristol-Myers-Squibb Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Bristol-Myers-Squibb Anti-Viral Drugs Products Offered
12.3.5 Bristol-Myers-Squibb Recent Development
12.4 AbbVie
12.4.1 AbbVie Corporation Information
12.4.2 AbbVie Description and Business Overview
12.4.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
12.4.4 AbbVie Anti-Viral Drugs Products Offered
12.4.5 AbbVie Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Corporation Information
12.5.2 Johnson & Johnson Description and Business Overview
12.5.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Johnson & Johnson Anti-Viral Drugs Products Offered
12.5.5 Johnson & Johnson Recent Development
12.6 Merck & Co
12.6.1 Merck & Co Corporation Information
12.6.2 Merck & Co Description and Business Overview
12.6.3 Merck & Co Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Merck & Co Anti-Viral Drugs Products Offered
12.6.5 Merck & Co Recent Development
12.7 Aurobindo Pharma
12.7.1 Aurobindo Pharma Corporation Information
12.7.2 Aurobindo Pharma Description and Business Overview
12.7.3 Aurobindo Pharma Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Aurobindo Pharma Anti-Viral Drugs Products Offered
12.7.5 Aurobindo Pharma Recent Development
12.8 Cipla
12.8.1 Cipla Corporation Information
12.8.2 Cipla Description and Business Overview
12.8.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Cipla Anti-Viral Drugs Products Offered
12.8.5 Cipla Recent Development
12.9 Dr Reddy's
12.9.1 Dr Reddy's Corporation Information
12.9.2 Dr Reddy's Description and Business Overview
12.9.3 Dr Reddy's Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Dr Reddy's Anti-Viral Drugs Products Offered
12.9.5 Dr Reddy's Recent Development
12.11 F. Hoffmann-La Roche
12.11.1 F. Hoffmann-La Roche Corporation Information
12.11.2 F. Hoffmann-La Roche Description and Business Overview
12.11.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
12.11.4 F. Hoffmann-La Roche Anti-Viral Drugs Products Offered
12.11.5 F. Hoffmann-La Roche Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Anti-Viral Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-Viral Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Anti-Viral Drugs Market Segments
Table 2. Ranking of Global Top Anti-Viral Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anti-Viral Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Nucleotide Polymerase Inhibitor
Table 5. Major Manufacturers of Reverse Transcriptase Inhibitor
Table 6. Major Manufacturers of Protease Inhibitor
Table 7. Global Anti-Viral Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Anti-Viral Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Anti-Viral Drugs Sales by Regions 2015-2020 (K Units)
Table 10. Global Anti-Viral Drugs Sales Market Share by Regions (2015-2020)
Table 11. Global Anti-Viral Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Anti-Viral Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 13. Global Anti-Viral Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global Anti-Viral Drugs Sales Share by Manufacturers (2015-2020)
Table 15. Global Anti-Viral Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Anti-Viral Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Viral Drugs as of 2019)
Table 17. Anti-Viral Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Anti-Viral Drugs Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Anti-Viral Drugs Price (2015-2020) (USD/Unit)
Table 20. Anti-Viral Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Anti-Viral Drugs Product Type
Table 22. Date of International Manufacturers Enter into Anti-Viral Drugs Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Anti-Viral Drugs Sales by Type (2015-2020) (K Units)
Table 25. Global Anti-Viral Drugs Sales Share by Type (2015-2020)
Table 26. Global Anti-Viral Drugs Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Anti-Viral Drugs Revenue Share by Type (2015-2020)
Table 28. Anti-Viral Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global Anti-Viral Drugs Sales Share by Type (2021-2026)
Table 30. Global Anti-Viral Drugs Sales by Application (2015-2020) (K Units)
Table 31. Global Anti-Viral Drugs Sales Share by Application (2015-2020)
Table 32. Global Anti-Viral Drugs Sales Share by Application (2021-2026)
Table 33. Global Anti-Viral Drugs Sales Market Share Forecast by Application (2021-2026)
Table 34. Global Anti-Viral Drugs Revenue by Application (2015-2020) (US$ Million)
Table 35. Global Anti-Viral Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 36. Japan Anti-Viral Drugs Sales (K Units) of Key Companies (2015-2020)
Table 37. Japan Anti-Viral Drugs Sales Share by Company (2015-2020)
Table 38. Japan Anti-Viral Drugs Revenue (US$ Million) by Company (2015-2020)
Table 39. Japan Anti-Viral Drugs Sales (K Units) by Type (2015-2020)
Table 40. Japan Anti-Viral Drugs Sales Share by Type (2015-2020)
Table 41. Japan Anti-Viral Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 42. Japan Anti-Viral Drugs Price (K Units) by Type (2015-2020)
Table 43. Japan Anti-Viral Drugs Sales (K Units) by Type (2021-2026)
Table 44. Japan Anti-Viral Drugs Sales Share by Type (2021-2026)
Table 45. Japan Anti-Viral Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 46. Japan Anti-Viral Drugs Revenue Share by Type (2021-2026)
Table 47. Japan Anti-Viral Drugs Price (K Units) by Type (2021-2026)
Table 48. Japan Anti-Viral Drugs Sales (K Units) by Application (2015-2020)
Table 49. Japan Anti-Viral Drugs Sales Share by Application (2015-2020)
Table 50. Japan Anti-Viral Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 51. Japan Anti-Viral Drugs Sales (K Units) by Application (2021-2026)
Table 52. Japan Anti-Viral Drugs Sales Share by Application (2021-2026)
Table 53. Japan Anti-Viral Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 54. Japan Anti-Viral Drugs Revenue Share by Application (2021-2026)
Table 55. North America Anti-Viral Drugs Sales by Country (2015-2020) (K Units)
Table 56. North America Anti-Viral Drugs Sales Market Share by Country (2015-2020)
Table 57. North America Anti-Viral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 58. North America Anti-Viral Drugs Revenue Market Share by Country (2015-2020)
Table 59. Europe Anti-Viral Drugs Sales by Country (2015-2020) (K Units)
Table 60. Europe Anti-Viral Drugs Sales Market Share by Country (2015-2020)
Table 61. Europe Anti-Viral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 62. Europe Anti-Viral Drugs Revenue Market Share by Country (2015-2020)
Table 63. Asia Pacific Anti-Viral Drugs Sales by Region (2015-2020) (K Units)
Table 64. Asia Pacific Anti-Viral Drugs Sales Market Share by Region (2015-2020)
Table 65. Asia Pacific Anti-Viral Drugs Revenue by Region (2015-2020) (US$ Million)
Table 66. Asia Pacific Anti-Viral Drugs Revenue Market Share by Region (2015-2020)
Table 67. Latin America Anti-Viral Drugs Sales by Country (2015-2020) (K Units)
Table 68. Latin America Anti-Viral Drugs Sales Market Share by Country (2015-2020)
Table 69. Latin Americaa Anti-Viral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 70. Latin America Anti-Viral Drugs Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Anti-Viral Drugs Sales by Country (2015-2020) (K Units)
Table 72. Middle East and Africa Anti-Viral Drugs Sales Market Share by Country (2015-2020)
Table 73. Middle East and Africa Anti-Viral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 74. Middle East and Africa Anti-Viral Drugs Revenue Market Share by Country (2015-2020)
Table 75. F. Hoffmann-La Roche Corporation Information
Table 76. F. Hoffmann-La Roche Description and Business Overview
Table 77. F. Hoffmann-La Roche Anti-Viral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. F. Hoffmann-La Roche Anti-Viral Drugs Product
Table 79. F. Hoffmann-La Roche Recent Development
Table 80. GlaxoSmithKline Corporation Information
Table 81. GlaxoSmithKline Description and Business Overview
Table 82. GlaxoSmithKline Anti-Viral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. GlaxoSmithKline Product
Table 84. GlaxoSmithKline Recent Development
Table 85. Bristol-Myers-Squibb Corporation Information
Table 86. Bristol-Myers-Squibb Description and Business Overview
Table 87. Bristol-Myers-Squibb Anti-Viral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Bristol-Myers-Squibb Product
Table 89. Bristol-Myers-Squibb Recent Development
Table 90. AbbVie Corporation Information
Table 91. AbbVie Description and Business Overview
Table 92. AbbVie Anti-Viral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. AbbVie Product
Table 94. AbbVie Recent Development
Table 95. Johnson & Johnson Corporation Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson Anti-Viral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Johnson & Johnson Product
Table 99. Johnson & Johnson Recent Development
Table 100. Merck & Co Corporation Information
Table 101. Merck & Co Description and Business Overview
Table 102. Merck & Co Anti-Viral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Merck & Co Product
Table 104. Merck & Co Recent Development
Table 105. Aurobindo Pharma Corporation Information
Table 106. Aurobindo Pharma Description and Business Overview
Table 107. Aurobindo Pharma Anti-Viral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Aurobindo Pharma Product
Table 109. Aurobindo Pharma Recent Development
Table 110. Cipla Corporation Information
Table 111. Cipla Description and Business Overview
Table 112. Cipla Anti-Viral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Cipla Product
Table 114. Cipla Recent Development
Table 115. Dr Reddy's Corporation Information
Table 116. Dr Reddy's Description and Business Overview
Table 117. Dr Reddy's Anti-Viral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Dr Reddy's Product
Table 119. Dr Reddy's Recent Development
Table 120. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 121. Key Challenges
Table 122. Market Risks
Table 123. Main Points Interviewed from Key Anti-Viral Drugs Players
Table 124. Anti-Viral Drugs Customers List
Table 125. Anti-Viral Drugs Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Viral Drugs Product Picture
Figure 2. Global Anti-Viral Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Nucleotide Polymerase Inhibitor Product Picture
Figure 4. Reverse Transcriptase Inhibitor Product Picture
Figure 5. Protease Inhibitor Product Picture
Figure 6. Global Anti-Viral Drugs Sales Market Share by Application in 2020 & 2026
Figure 7. HIV
Figure 8. Hepatitis
Figure 9. HSV
Figure 10. Influenza
Figure 11. Anti-Viral Drugs Report Years Considered
Figure 12. Global Anti-Viral Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Anti-Viral Drugs Sales 2015-2026 (K Units)
Figure 14. Global Anti-Viral Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Anti-Viral Drugs Sales Market Share by Region (2015-2020)
Figure 16. Global Anti-Viral Drugs Sales Market Share by Region in 2019
Figure 17. Global Anti-Viral Drugs Revenue Market Share by Region (2015-2020)
Figure 18. Global Anti-Viral Drugs Revenue Market Share by Region in 2019
Figure 19. Global Anti-Viral Drugs Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Anti-Viral Drugs Revenue in 2019
Figure 21. Anti-Viral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Anti-Viral Drugs Sales Market Share by Type (2015-2020)
Figure 23. Global Anti-Viral Drugs Sales Market Share by Type in 2019
Figure 24. Global Anti-Viral Drugs Revenue Market Share by Type (2015-2020)
Figure 25. Global Anti-Viral Drugs Revenue Market Share by Type in 2019
Figure 26. Global Anti-Viral Drugs Market Share by Price Range (2015-2020)
Figure 27. Global Anti-Viral Drugs Sales Market Share by Application (2015-2020)
Figure 28. Global Anti-Viral Drugs Sales Market Share by Application in 2019
Figure 29. Global Anti-Viral Drugs Revenue Market Share by Application (2015-2020)
Figure 30. Global Anti-Viral Drugs Revenue Market Share by Application in 2019
Figure 31. Japan Anti-Viral Drugs Sales Growth Rate 2015-2026 (K Units)
Figure 32. Japan Anti-Viral Drugs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 33. Japan Anti-Viral Drugs Market Share in Global Market 2015-2026
Figure 34. Japan 5 and 10 Largest Anti-Viral Drugs Players Market Share by Revenue in Anti-Viral Drugs in 2019
Figure 35. Japan Anti-Viral Drugs Revenue Share by Type (2015-2020)
Figure 36. Japan Anti-Viral Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 37. Japan Anti-Viral Drugs Revenue Share by Application (2015-2020)
Figure 38. Japan Anti-Viral Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 39. North America Anti-Viral Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 40. North America Anti-Viral Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. North America Anti-Viral Drugs Sales Market Share by Country in 2019
Figure 42. North America Anti-Viral Drugs Revenue Market Share by Country in 2019
Figure 43. U.S. Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 44. U.S. Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Canada Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. Canada Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Europe Anti-Viral Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 48. Europe Anti-Viral Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 49. Europe Anti-Viral Drugs Sales Market Share by Country in 2019
Figure 50. Europe Anti-Viral Drugs Revenue Market Share by Country in 2019
Figure 51. Germany Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Germany Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. France Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. France Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. U.K. Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 56. U.K. Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Italy Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 58. Italy Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Russia Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 60. Russia Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Asia Pacific Anti-Viral Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 62. Asia Pacific Anti-Viral Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Anti-Viral Drugs Sales Market Share by Region in 2019
Figure 64. Asia Pacific Anti-Viral Drugs Revenue Market Share by Region in 2019
Figure 65. China Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. China Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. Japan Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. South Korea Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. India Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Australia Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Taiwan Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Indonesia Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Thailand Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 82. Malaysia Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 84. Philippines Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 86. Vietnam Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Latin America Anti-Viral Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 88. Latin America Anti-Viral Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Anti-Viral Drugs Sales Market Share by Country in 2019
Figure 90. Latin America Anti-Viral Drugs Revenue Market Share by Country in 2019
Figure 91. Mexico Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Mexico Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 94. Brazil Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 96. Argentina Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Middle East and Africa Anti-Viral Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Anti-Viral Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Anti-Viral Drugs Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Anti-Viral Drugs Revenue Market Share by Country in 2019
Figure 101. Turkey Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Anti-Viral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Anti-Viral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Porter's Five Forces Analysis
Figure 108. Anti-Viral Drugs Value Chain
Figure 109. Channels of Distribution
Figure 110. Distributors Profiles
Figure 111. Bottom-up and Top-down Approaches for This Report
Figure 112. Data Triangulation
Figure 113. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs